Department of Neurosurgery, Shinshu University School of Medicine, Matsumoto, Japan.
Department of Neurosurgery, Shinshu University School of Medicine, Matsumoto, Japan.
World Neurosurg. 2020 Dec;144:19-23. doi: 10.1016/j.wneu.2020.08.129. Epub 2020 Aug 24.
Spontaneous cerebrospinal fluid (CSF) rhinorrhea associated with untreated prolactinomas is rare, which is in contrast to medical treatment-induced CSF rhinorrhea. Previous studies have suggested that cessation of drug administration should be the first line of treatment for prolactinoma with medically induced CSF rhinorrhea. On the other hand, there is no standard treatment strategy for prolactinoma with the development of spontaneous CSF rhinorrhea, because of its complicated pathology. Here, we report a case of giant invasive macroprolactinoma with spontaneous CSF rhinorrhea, and discuss the treatment strategy for this complicated condition with a review of the relevant literature.
A previously healthy 39-year-old man presented with 1-year history of intermittent clear fluid nasal discharge with headache and vomiting. Magnetic resonance imaging showed a large parasellar mass with destruction of the skull base. This tumor was diagnosed as prolactinoma with hypopituitarism based on the results of hormone examinations. Tumor resection with skull base reconstruction in the endoscopic endonasal approach was performed because CSF rhinorrhea was aggravated by bromocriptine loading test and administration of dopamine agonist. Life-threatening bacterial meningitis occurred after surgery, which was cured with antibiotics along with resolution the CSF rhinorrhea.
Careful consideration is necessary before applying standard first-line protocols with dopamine agonist administration in patients with prolactinoma, especially in cases with spontaneous CSF rhinorrhea. An appropriate treatment strategy should be planned according to the individual case, including factors such age, sex, pituitary function, tumor mass size, prolactin concentration, and condition of CSF leakage.
未经治疗的泌乳素瘤并发自发性脑脊液(CSF)鼻漏较为罕见,而药物治疗引起的 CSF 鼻漏则较为常见。既往研究表明,对于药物治疗引起的 CSF 鼻漏的泌乳素瘤,应首先停止药物治疗。另一方面,对于自发性 CSF 鼻漏的泌乳素瘤,由于其病理复杂,尚无标准的治疗策略。本文报道了 1 例伴有自发性 CSF 鼻漏的巨大侵袭性垂体泌乳素瘤病例,并结合相关文献讨论了这种复杂情况的治疗策略。
一位 39 岁的既往体健男性,以间歇性清亮液体鼻漏伴头痛和呕吐 1 年为主诉就诊。磁共振成像显示鞍旁有一个大的肿块,破坏颅底。根据激素检查结果,该肿瘤被诊断为伴有垂体功能减退的泌乳素瘤。由于溴隐亭负荷试验和多巴胺激动剂给药加重了 CSF 鼻漏,因此采用内镜经鼻入路进行肿瘤切除术和颅底重建。术后发生危及生命的细菌性脑膜炎,经抗生素治疗后治愈,同时 CSF 鼻漏也得到了缓解。
在对泌乳素瘤患者应用多巴胺激动剂标准一线方案之前,需要仔细考虑,特别是对于自发性 CSF 鼻漏的患者。应根据个体情况制定适当的治疗策略,包括年龄、性别、垂体功能、肿瘤大小、泌乳素浓度和 CSF 漏出情况等因素。